Latest Publications
All →
Timor-Leste: Factsheet 2024Expanded programme on Immunization (EPI)

Timor-Leste: Fact Sheet 2023Expanded Programme on Immunization (EPI)

The WHO updated its guidance for the management of Drug-Susceptible TB (DS-TB), Drug-Resistant TB (DR-TB), Patient Care, Latent TB Infection (LTBI) and...

National Plan for Accelerated Actions for Ending TB: 2021-2025
The National Plan for accelerating efforts to End TB 2021-25 is drawn from the National Strategic Plan (NSP) for Ending TB developed through...

The Joint HIV-TB External Review Mission 2023
TB programme Timor-Leste, with an estimated incidence of 486 cases per 100 000 population in 2021, is the seventh highest TB burden country in the...

Guidelines for Antiretroviral Therapy & Management of Opportunistic Infections for Children, Adolescents...
This guideline aims to provide guidance and support to health care workers involved in the HIV/AIDS clinical management, including ART and OI, in...

National Strategic Plan for HIV, STIs and Viral Hepatitis
The Ministry of Health, Timor-Leste, has decided to develop an integrated National Strategic Plan (NSP) for HIV/AIDS, STIs and viral hepatitis, 2022-2026...

Social and Behaviour Change Communication Strategy for Prevention of Re-establishment of Malaria Transmission...
The National Strategic Plan for Prevention of Re-establishment of Malaria 2021–2025 has been developed based on Timor-Leste's experience in malaria...

National Strategic Plan for Leprosy, 2022–2025 Timor-Leste
Within the last decade, Timor-Leste has experienced a significantdecline in the burden of leprosy. However, leprosy remains a public health problem with...

National Guideline for Clinical Management of Dengue 2022
There has been an eight-fold rise in the number of dengue cases reported to WHO over the last two decades, from 505 430 cases in 2000 to over 2.4 million...

An analysis of the malaria situation in Timor-Leste reveals that the disease has largely been contained to cross-border areas. The decrease in malaria...

Timor-Leste is committed to ʻTriple Eliminationʼ of MTCT of HIV/AIDS syphilis and hepatitis B by 2030. The External Mid-Term Review had noted that Timor-Leste...

TB Epidemiological Review 2023 Timor-Leste
Timor-Leste’s National TB Programme (NTP) is known for fast uptake of new recommendations into routine programming, innovative and sustainable solutions...

Road Map of Preparatory Activities for Designating Klibur Domin as the National Centre of Excellence...
To address the substantial challenges of DR-TB, the National Tuberculosis Program (NTP) intends to designate Klibur Domin as the Center of Excellence...
-in-timor-leste.tmb-144v.jpg?Culture=en&sfvrsn=ddfb8bc3_1)
Experience on the first national anti-TB drug resistance survey (DRS) in Timor-Leste
Abstract Background: A national drug resistance survey (DRS) was implemented for the frst time in Timor-Leste (TL) in 2019. The primary objective of the...

The baseline study had two objectives: to establish impact and outcome/output indicators for future evaluation, and to inform the targeting and design...

Timor-Leste has the 2nd highest TB incidence rate in the WHO South-East Asia Region after North Korea. According to data released by the WHO in 2020, total...